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Abstract
Background: The excitatory amino acid domoic acid, a glutamate and kainic acid analog, is the causative agent
of amnesic shellfish poisoning in humans. No studies to our knowledge have investigated the potential
contribution to short-term neurotoxicity of the brain microglia, a cell type that constitutes circa 10% of the total
glial population in the brain. We tested the hypothesis that a short-term in vitro exposure to domoic acid, might
lead to the activation of rat neonatal microglia and the concomitant release of the putative neurotoxic mediators
tumor necrosis factor-α  (TNF-α ), matrix metalloproteinases-2 and-9 (MMP-2 and -9) and superoxide anion (O2-).
Results: In vitro, domoic acid [10 µM-1 mM] was significantly neurotoxic to primary cerebellar granule neurons.
Although neonatal rat microglia expressed ionotropic glutamate GluR4 receptors, exposure during 6 hours to
domoic acid [10 µM-1 mM] had no significant effect on viability. By four hours, LPS (10 ng/mL) stimulated an
increase in TNF-α  mRNA and a 2,233 % increase in TNF-α  protein In contrast, domoic acid (1 mM) induced a
slight rise in TNF-α  expression and a 53 % increase (p < 0.01) of immunoreactive TNF-α  protein. Furthermore,
though less potent than LPS, a 4-hour treatment with domoic acid (1 mM) yielded a 757% (p < 0.01) increase in
MMP-9 release, but had no effect on MMP-2. Finally, while PMA (phorbol 12-myristate 13-acetate) stimulated O2-
generation was elevated in 6 hour LPS-primed microglia, a similar pretreatment with domoic acid (1 mM) did not
prime O2- release.
Conclusions:  To our knowledge this is the first experimental evidence that domoic acid, at in vitro
concentrations that are toxic to neuronal cells, can trigger a release of statistically significant amounts of TNF-α
and MMP-9 by brain microglia. These observations are of considerable pathophysiological significance because
domoic acid activates rat microglia several days after in vivo administration.
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Background
Microglia are leukocytes derived outside the central
nervous system in the bone marrow, from where they en-
ter the circulation as monocytes and migrate into the
brain during late embryonic life establishing permanent
residency [1]. Two different phenotypic forms of micro-
glia are known: the activated but nonphagocytic micro-
glia, which play a role in inflammatory pathologies, and
the reactive or phagocytic microglia which participate
actively in trauma, infection and neuronal degeneration
[2].
In vivo as well as in vitro administration of LPS rapidly
and potently activates rat adult and neonatal microglia
(for review see Ref. [3]). Accompanying both adult and
neonatal microglia activation by LPS [4] is a concomitant
release of numerous secretory products (for review see
Ref. [3]) that include tissue plasminogen activator [5],
reactive oxygen species such as O2- [6,7], cytokines like
TNF-α  [7,8] and proteases, in particular MMP-9 [7,9], in
a time- and concentration-dependent manner. These
mediators have been implicated in sublethal and lethal
neuronal and glial injury [10], neuronal degeneration
[3,11,12] that could potentially affect neurodevelopment
in the immature brain.
Exposure to the marine toxin domoic acid, an excitotoxic
amino acid structurally similar to kainic acid and to the
neurotransmitter glutamic acid, has been shown to lead
to amnesic shellfish poisoning in humans, a condition
that can lead to death in extreme cases [13]. Currently,
the Center for Food Safety and Applied Nutrition, US.
Food and Drug Administration has included amnesic
shellfish poisoning as one of the "...five recognized fish
poisoning syndromes in the United States...", together
with paralytic, neurotoxic, diarrhetic and ciguatera fish
poisoning (FDA website:  [http://vm.cfsan.fda.gov/
~dms/haccp-2f.html] ) [14]. Recent behavioral toxicity
studies in rodents, have confirmed that domoic acid is a
very rapid and potent neurotoxin in newborn rats, at
doses far lower than in adult animals [15–17]. Even
though hippocampal pyramidal neurons and mossy fiber
terminals appear to be selectively targeted in vivo by do-
moic acid in rat [18] and cynomolgus monkey brain [19],
recently domoic acid was shown to affect glutamate up-
take by astrocytes in vitro and "...thus produced neuro-
toxicity..." [20]. Of interest is the fact that no studies to
our knowledge have investigated the potential contribu-
tion of brain microglia to neonatal neurotoxicity after a
short-term exposure to domoic acid [21].
The possibility that domoic acid may activate neonatal
microglia both in vitro and in vivo is suggested by recent
observations with kainic acid, a domoic acid and gluta-
mate analog that can induce upregulation of neonatal
microglia scavenger receptor mRNA [22] and tissue
plasminogen activator release [23]. The putative molec-
ular explanation for these observations has been that
kainic acid activates the ionotropic AMPA glutamate
GluR4 subunit which has recently been shown to be ex-
pressed by activated microglia following transient fore-
brain ischemia in vivo [24]. Because this subunit of the
AMPA glutamate receptor has affinity for domoic acid
[25–27], we hypothesized that domoic acid might acti-
vate neonatal microglia in vitro and lead to concomitant
mediator release [21].
The purpose of this investigation was to determine if a
short-term in vitro exposure to domoic acid might acti-
vate rat neonatal microglia and cause mediator release.
Using LPS, which we have previously shown is a rapid
and potent in vitro activator of neonatal microglia [7] as
our positive control, we focused our investigation on
three microglia mediators which are released upon LPS
activation, namely TNF-α , MMP-9 and O2- [7]. Our
present study demonstrates that in contrast to LPS, dur-
ing a 6 hour in vitro exposure to domoic acid, neonatal
Figure 1
Determination of Domoic acid by electrospray mass
spectrometry.  (A) The electrospray mass spectrometry
spectrum of 12.5 mM Domoic acid shows that the dominate
ion in the spectrum is m/z 312.2, the pseudomolecular ion
[M+H+] of Domoic acid, demonstrating that undegraded
Domoic acid was present in the 12.5 mM stock solution; (B)
The electrospray mass spectrometry spectrum of 0.0025 mM
Domoic acid, the highest dilution used in the experiments,
also shows the presence of undegraded Domoic acid.BMC Pharmacology 2001, 1:7 http://www.biomedcentral.com/1471-2210/1/7
rat microglia release small, but statistically significant
amounts of TNF-α  and MMP-9. Furthermore our obser-
vations suggest that in vivo, brain microglia as well as the
mediators released by this cell type in brain tissue, would
appear to play a limited role in the rapid and potent do-
moic acid neurotoxicity observed in neonatal rats after a
short-term administration of domoic acid.
Results
Determination of domoic acid by electrospray mass spec-
trometry
The presence of undegraded domoic acid in both stock
solution (12.5 mM) and dilutions prepared with LPS-free
water was confirmed by electrospray mass spectrometry
prior to the experiments. As shown for the 12.5 mM do-
moic acid stock solution in Fig. 1A, the dominate ion in
the spectrum was m/z 312.2 which is the pseudomolecu-
lar ion [M+H]+ of domoic acid. Also present in the spec-
trum were m/z 334.2, the sodium adduct [M+Na]+ of
domoic acid, m/z 623.3, the dimer [2M+H]+ of domoic
acid, and m/z 645.4 [2M+Na]+, the sodium adduct of the
dimer. The dimer was formed in the gas phase due to the
high concentration of the sample. Mass spectra for dilu-
tion of 2.5, 0.25 and 0.025 mM also showed as the dom-
inate ion m/z 312, domoic acid [M+H]+ (data not
shown). As shown in Fig. 1B, for the lowest domoic acid
concentration used in our studies, namely 0.0025 mM
domoic acid, although background noise dominated the
sample, m/z 312.2, the domoic acid [M+H]+ was clearly
seen in the spectrum.
Immunofluorescent visualization of CD11b/c and glutama-
te receptor subunit GluR4 in rat neonatal microglia
It has recently been reported that transient forebrain
ischemia leads to the expression of the inotropic AMPA
glutamate receptor GluR4 subunit in vivo [24] in rat ne-
onatal microglia. In order to ascertain that under our ex-
perimental conditions rat neonatal microglia expressed
the GluR4 subunit, we studied the expression of the
AMPA receptor GluR4 by immunohistochemistry. The
top left photo in Fig. 2 shows a bright field, phase con-
trast view of microglia that were incubated in the ab-
sence of the primary antibodies against GluR4 and
CD11b/c. Note that the microglia are irregular in shape
and show numerous elongated processes extending from
the bodies of the cells. In addition, numerous vesicular
structures are present in the cytoplasm of the microglia.
The top right photo shows the same microglia when
viewed using the FITC filter configuration. Note that the
vesicular structures exhibit an intense autofluorescence,
but that little or no fluorescence is evident over most of
the microglia cell bodies or in the elongated processes.
Interestingly, this same pattern of autofluorescence was
evident when the microglia were viewed with the TRITC
filter configuration (not shown). The middle left photo
shows a bright field, phase contrast view of microglia
that had been labeled with the antibodies against the
Figure 2
Immunofluorescent visualization of CD11b/c and
ionotropic glutamate receptor subunit GluR4 in neo-
natal rat brain microglia. The integrin CD11b/c and the
ionotropic glutamate receptor subunit GluR4 were visualized
using the dual-labeling indirect immunofluorescent technique
(See Materials and Methods). (Top left) bright field, phase
contrast view of microglia incubated in the absence of the
primary antibodies against GluR4 and CD11b/c. (Top right)
same microglia viewed using FITC filter configuration. Note
vesicular structures exhibiting intense autofluorescence, but
little or no fluorescence over most of the microglia cell bod-
ies or the elongated processes. (Middle left) bright field,
phase contrast view of microglia labeled with anti-glutamate
receptor GluR4 subunit and the leukocyte marker CD11b/c.
(Middle right)(green) same field viewed using the FITC fil-
ter configuration. Microglia not only contain fluorescent vesi-
cles, but exhibit a prominent speckled pattern of
fluorescence over the cell bodies and the elongated proc-
esses. Absence of speckled pattern of labeling in cells incu-
bated without primary GluR4 antibody (compare with top
right photo) suggests the speckled pattern represents specific
labeling of GluR4 subunit. (Lower left) same microglia
exhibited intense labeling of CD11b/c (red), which confirms
microglia are of leukocytic origin. (Bottom right) GluR4
and CD11b/c superimposed labeling (yellow). Approximate
magnification of the original was ×  525.BMC Pharmacology 2001, 1:7 http://www.biomedcentral.com/1471-2210/1/7
glutamate receptor GluR4 subunit and the leukocyte
marker CD11b/c. Again, the microglia are irregular in
shape, with elongated processes extending from the cell
bodies and numerous vesicles present in the cytoplasm.
The middle right photo (green) shows this same field
when viewed using the FITC filter configuration. As evi-
dent, the microglia not only contain fluorescent vesicles,
but also exhibit a prominent speckled pattern of fluores-
cence over the cell bodies and the elongated processes.
The fact that this speckled pattern of labeling is not
present in the samples that were incubated without the
primary GluR4 antibody (compare with top right photo)
strongly indicates that the speckled pattern represents
specific labeling of GluR4 subunit. The lower left photo
shows that these same microglia exhibited intense labe-
ling of CD11b/c (red), which confirms that the microglia
are of leukocytic origin. In the bottom right photo the im-
ages showing the GluR4 and the CD11b/c labeling have
been superimposed (yellow). Together, these results in-
dicate that GluR4 glutamate receptor subunits are
present on the cell surface and that these cells are, in fact,
microglia.
Effect of domoic acid on cerebellar granule cell and rat ne-
onatal microglia viability
Domoic acid has been reported to be neurotoxic to neu-
ronal tissue in vitro in concentrations ranging from 10
µM to 20 mM [28–33]. In order to determine a concen-
tration of domoic acid that was neurotoxic in vitro during
a 6 hour exposure, we investigated the concentration-de-
pendent effect of domoic acid on cerebellar granule neu-
rons using the WST-1 viability assay. This assay
measures cell viability as a function of cleavage of the
tetrazolium salt WST-1 by mitochondrial dehydrogenas-
es in viable cells to formazan. As shown in Fig. 3C and 3D
the viability of primary cerebellar granule cells exposed
for up to 6 hours to domoic acid [10 µM-1 mM] was sig-
nificantly affected (P < 0.05). In contrast to our observa-
tions with cerebellar granule neurons, domoic acid even
at the highest neurotoxic concentration tested in our in
vitro study, namely [1 mM] did not affect microglia via-
bility during a 6 hour exposure (Fig 3A and 3B). Because
1 mM domoic acid was clearly neurotoxic in our studies,
this concentration was selected for all in vitro experi-
ments with microglia. LPS (10 ng/ml) did not affect mi-
croglia viability in vitro during a 6 hour exposure (data
not shown).
Effect of LPS and domoic acid on TNF-α  mRNA expression 
from rat neonatal microglia
Activation of microglia has been shown to cause the re-
lease of cytokines such as TNF-α  [7,8]. As shown in Fig.
4A, stimulation of microglia with LPS [10 ng/ml] result-
ed in a time-dependent increase in TNF-α  mRNA ex-
pression relative to controls as determined by semi-
quantitative RT-PCR at the linear range of amplification
(20 cycles). Without LPS treatment (control), TNF-α
mRNA expression was undetectable. As shown in Fig. 5,
the relative levels of TNF-α  expression increased 4.5 fold
by 1 hour and remained elevated throughout the 6 hour
observation period. In contrast to the marked increase in
TNF-α  expression induced by LPS, as shown in Fig. 4B,
domoic acid [1 mM] induced a less potent yet time-de-
pendent increase in TNF-α  mRNA expression as deter-
mined by semi-quantitative RT-PCR over the linear
range of amplification (25 cycles). As shown in Fig. 5, al-
though not statistically significant, the relative levels of
TNF-α  expression increased two-fold by 4 hours and re-
mained elevated during the next two hours.
Effect of domoic acid and LPS on rat neonatal microglia 
release of TNF-α
In order to determine if the increase in TNF-α  mRNA af-
ter a short term stimulation with either domoic acid [1
mM] or LPS [10 ng/mL] led to a concomitant production
of TNF-α  protein, the cell-free media corresponding to
the same microglia used for TNF-α  mRNA analysis were
assayed with an ultrasensitive rat-specific ELISA. As ex-
Figure 3
Effect of a 6 hour exposure of Domoic acid on neona-
tal rat brain microglia and primary cerebellar gran-
ule cell viability as determined by the WST-1 assay
(See Materials and Methods). Domoic acid did not affect via-
bility of neonatal rat brain microglia in either a (A) concen-
tration or (B) time-dependent manner. Domoic acid [10 µM
– 1 mM] significantly affected viability of primary cerebellar
granule cells in both a (C) concentration and (D) time-
dependent manner. Data (absorbance of formazan formation
at 450 nM) are expressed as mean ± SD of values obtained
from one representative experiment (n = 4–8). *p < 0.05 vs
vehicle control.BMC Pharmacology 2001, 1:7 http://www.biomedcentral.com/1471-2210/1/7
pected and shown in Fig. 6, LPS [10 ng/mL] stimulated
microglia time-dependent TNF-α  release: by 4 hours
TNF-α  levels increased 2,233 % and were 298.7 ± 3.9 pg/
mL (LPS-treated, n = 4) vs. 12.8 ± 2.6 pg/mL (untreated
controls, n = 8), P < 0.01. In contrast to LPS, levels of im-
munoreactive TNF-α  in the tissue culture media in-
creased 53.3 % 4 hours after microglia were treated with
domoic acid [1 mM] and were 28.2 ± 3.6 pg/mL (domoic
acid-treated, n = 6) vs. 18.4 ± 1.99 pg/mL (untreated con-
trols, n = 10), P < 0.01. Interestingly, the 4 hour time
point corresponded to the highest level of TNF-α  mRNA
expression shown in Fig. 5.
Effect of domoic acid and LPS on rat neonatal microglia 
release of MMP-2 and MMP-9
We have recently shown that a stimulation of microglia
with LPS will lead to both TNF-α  generation and MMP-
9 production, a mediator that has been reported to be
toxic to neuronal tissue [7]. As shown in Fig. 7, when mi-
croglia were stimulated with LPS [10 ng/mL], an in-
crease in MMP-9 and MMP-2 release was observed: by 4
hours MMP-9 inverse O.D. levels increased 2,100 % and
were respectively 0.198 ± 0.009 (LPS-treated, n = 3) vs.
0.009 ± 0.001 (untreated controls, n = 3), P < 0.01. In
contrast to LPS, a 757 % increase in MMP-9 levels was
observed in the tissue culture media 4 hours after micro-
glia were treated with domoic acid [1 mM]: inverse O.D.
levels were respectively 0.06 ± 0.01 (domoic acid-treat-
ed, n = 3) vs. 0.007 ± 0.001 (untreated controls, n = 3), P
< 0.01. Domoic acid [1 mM] had no effect on MMP-2 re-
lease.
Effect of domoic acid and LPS on rat neonatal microglia 
release of O2-
We have shown that while unprimed naive microglia re-
lease low levels of O2-, pretreatment with LPS results in
an increase of PMA-stimulated O2- [7]. As is depicted in
Fig. 8A, when microglia were pretreated for 6 hours with
LPS [10 ng/mL], there was, as expected, an increase in
PMA [1 µM]-stimulated O2- production: 6.5 ± 0.9
nmoles/2 hours (LPS-pretreated, n = 3) vs. 1.7 ± 0.07
nmoles/2 hours (untreated controls, n = 3), P < 0.01. In
contrast, a 6 hour pretreatment of microglia with domoic
acid [1 mM], yielded no statistically significant increase
in PMA [1 µM]-stimulated O2- generation: 2.97 ± 0.44
nmoles/2 hours (domoic acid pretreated, n = 3) vs. 1.7 ±
0.07 nmoles/2 hours (untreated controls, n = 3). Fur-
thermore, domoic acid did not affect PMA [1 µM]-stimu-
lated O2- generation from 6 hour LPS-pretreated
microglia: 6.5 ± 0.9 nmoles/2 hours (LPS-pretreated, n =
3) vs. 6.26 ± 0.4 nmoles/2 hours (LPS + domoic acid pre-
treated, n = 3). Finally, as shown in Fig. 8B, though not
statistically significant, a 2 hour stimulation with in-
creasing concentrations of domoic acid and PMA [1 µM],
reduced O2- generation from 6 hours LPS-pretreated mi-
croglia: 4.16 ± 0.58 nmoles/2 hours (domoic acid [1 mM]
+ PMA [1 µM], n = 3) vs 6.5 ± 1.0 nmoles/2 hours (un-
treated controls, n = 3).
Discussion
Although domoic acid's excitotoxicity to adult neuronal
tissue in humans, rats, mice and monkeys is well docu-
mented (for review see Ref. [21]), a growing body of re-
search also suggests that there might be increased
vulnerability during the neonatal period [15–17]. The
fact that the blood-brain barrier is incomplete [34], pro-
vides a putative explanation as to why neonates and fetal
mice in utero appear to be more sensitive to neurotoxins
like domoic acid than adult animals [35–37]. Although
microglia contribute to circa 10% of the total glial cell
population in the central nervous system (For review see
Ref. [38]), to our knowledge, no previous studies have
investigated the potential role of microglia in mediating
Figure 4
RT-PCR transcript analysis of TNF-α  gene expres-
sion. Neonatal rat brain microglia (2.8–5 ×  106 cells/culture
dish) were treated with (A) LPS [10 ng/mL] or (B) Domoic
acid [1 mM] for 1 to 6 hours. (See Materials and Methods).
Amplification of TNF-α  and S12 genes shows the predicted
fragment size after separation on a 1.5 % agarose gel and vis-
ualization by SYBRR Gold nucleic acid staining. The S12
rRNA gene product was amplified for 25 cycles and demon-
strates equal loading of the gels. Quantification of the TNF-α
product was done after 20 cycles (LPS) or 25 cycles (Domoic
acid). The cycle numbers used for quantification were shown
to be in the linear range.BMC Pharmacology 2001, 1:7 http://www.biomedcentral.com/1471-2210/1/7
the neurotoxic effects of domoic acid in the developing
rat brain. We have recently hypothesized that the marine
toxin domoic acid might affect the developing brain by
directly activating neonatal rat microglia and causing a
subsequent release of potentially neurotoxic mediators
[21].
Prior to testing our hypothesis experimentally, and de-
termining whether domoic acid had the potential to di-
rectly activate rat neonatal microglia in vitro, we thought
that it was of critical importance to establish that: (1) the
domoic acid preparation used in these experiments was
stable, (2) rat neonatal microglia isolated by our method-
ology expressed the AMPA glutamate receptor GluR4
subunit which has been observed in activated rat micro-
glia in vivo [24] and, (3) to confirm that the domoic acid
concentration selected for our in vitro studies with rat
neonatal microglia was one that was clearly toxic to neu-
ronal cells in vitro after a short-term exposure.
Although it has been reported that the solubility of do-
moic acid in water is approximately 7.6 g/L (24.4 mM)
[39], rapid and complete dissolution of domoic acid was
only consistently observed in our laboratory when pre-
paring a stock domoic acid solution of 12.5 mM in certi-
fied LPS-free water. To rule out the possibility that
domoic acid might have degraded as a consequence of ei-
ther our preparative method or the subsequent freezing
(-80°C) and thawing of the domoic acid stock solution,
electrospray mass spectrometry was run on both the do-
moic acid stock solution (12.5 mM) and the dilutions pre-
pared prior to the experiments. Our electrospray mass
spectrometry results clearly showed that undegraded do-
moic acid was present, demonstrating the stability of do-
moic acid in the aqueous solutions that had been frozen
at -80°C and thawed prior to use in the experiments. In-
terestingly, our observations complement those recently
reported on domoic acid's stability in saline solutions
[40].
The ionotropic AMPA glutamate receptor GluR4 subunit
has been shown to be expressed by activated rat adult
microglia in vivo following transient forebrain ischemia
[24] and also in vitro by rat neonatal microglia [41]. Be-
cause it is well established that AMPA glutamate recep-
tors bind domoic acid with high affinity in the nanomolar
range [25], we investigated the presence of GluR4 in rat
neonatal microglia used in our in vitro experiments by a
dual-labeling indirect immunofluorescence technique.
Our results clearly confirmed that GluR4 was present in
the rat neonatal microglia used in our in vitro studies
with domoic acid, demonstrating that the protocol used
in our laboratory to isolate microglia did not appear to
affect the presence of the AMPA glutamate receptor
GluR4 subunits and their colocalization with the CD 11
b/c integrin.
The cytotoxicity of domoic acid to neuronal tissue in vit-
ro has been investigated over a wide range of concentra-
tions, namely at 10 µM with primary cultures of
cerebellar neurons [30,31] as well as hippocampal slices
Figure 5
Alterations in the time-dependent expression levels
of TNF-α  and ribosomal S12 genes in neonatal rat
brain microglia after treatment with LPS or Domoic
acid. Levels of gene expression were quantified as described
in Materials and Methods and were normalized to sl2 rRNA.
Relative expression levels were calculated by dividing the
experimental level at each time point by the level observed in
the control. Expression is relative to steady-state levels in
control (1.00). Data (relative expression level) is expressed
as mean ± SE of 3 independent experiments. *p < 0.05 or **p
< 0.01 vs. vehicle control.
Figure 6
The time-dependent effect of LPS and Domoic acid
on neonatal rat brain microglia TNF-α  release. Neo-
natal rat brain microglia (2.8–5 ×  106 cells/culture dish) were
treated with Domoic acid [1 mM] or LPS [10 ng/mL] for 1–6
hours. TNF-α  was determined as described under Materials
and Methods. Data (pg/mL) are expressed as mean ± SE of 2
independent experiments. **p < 0.01 vs. vehicle control.BMC Pharmacology 2001, 1:7 http://www.biomedcentral.com/1471-2210/1/7
[33], at 100 µM with cultured prenatal rat hippocampal
neurons [29] and at 20 mM with rat lumbar spinal in-
terneurons [28]. In order to determine a concentration
of domoic acid for our in vitro studies that was toxic to
cerebellar granule cells after a short-term exposure in
our experimental conditions, we completed a viability
study using the WST-1 method. The results of this study
demonstrated that even though the highest concentra-
tion of domoic acid tested, namely 1 mM, did not affect
rat neonatal microglia viability in vitro, domoic acid con-
centrations as low as 10 µM were clearly cytotoxic to cer-
ebellar granule neurons after a 6 hour exposure. Because
cerebellar granule cells appear to be inherently resistant
to the cytotoxic effects of excitatory amino acids and neu-
rotoxicity appears to be "...facilitated when cellular en-
ergy is limited in cultured cerebellar neurons..." [42],
perhaps manipulating the experimental conditions (e.g.
lowering the temperature to 22°C) might have enhanced
the intensity of the observed cytotoxicity to cerebellar
neurons even further, as was reported recently when cer-
ebellar granule cells were exposed to 10 µM domoic acid
for up to 24 hours [43]. Future work is necessary to de-
termine if similar changes in the experimental condi-
tions might also increase the toxicity of domoic acid to
rat neonatal microglia in vitro. It is interesting to note,
however, that in newborn mice a brief local application
of 2 mM domoic acid to the exposed cortical surface led
to a massive degeneration of AMPA/KA GluR receptor
positive Cajal-Retzius neurons [44], severe impairment
of cortical neuronal migration in vivo and malformation
of the domoic acid-treated neocortex [44]. Thus, because
1 mM domoic acid was clearly toxic to cerebellar granule
neurons both in vitro (our current study) and in vivo
[44], we selected 1 mM domoic acid for the experiments
with rat neonatal microglia reported herein.
Having determined that our domoic acid preparation
was stable and undegraded, that rat neonatal microglia
expressed GluR4 in vitro and that 1 mM domoic acid was
toxic to cerebellar granule neurons in vitro but did not
affect the viability of rat neonatal microglia, we then in-
vestigated whether a short term 1–6 hour exposure to 1
mM domoic acid would activate rat neonatal microglia in
vitro. In all our experiments we compared domoic acid's
effect with that of 10 ng/ml LPS, a potent and rapid mi-
croglia activator [7], to clearly show that rat neonatal mi-
croglia were able to become rapidly activated and release
mediators, i.e. TNF-α , MMP-9 and O2- upon short-term
in vitro treatment. We have recently reported on the ki-
netics of LPS activation of rat neonatal microglia and the
concomitant release of TNF-α  protein, MMP-9 and O2-
[7]. These three microglia mediators are currently
thought to participate in neuronal and glial injury in vivo
[10,45] .
TNF-α  is a cytokine that can mediate myelin and oli-
godendrocyte damage in vitro [10] and thought to play a
key role in central nervous system pathologies [3]. In vit-
ro E. coli LPS can trigger rat neonatal microglia to rapid-
ly activate TNF-α  gene expression and subsequent
protein release [46] in a concentration- and time-de-
pendent manner. Although in vitro exposure of rat neo-
natal microglia to 10 ng/ml LPS resulted, as expected, in
a rapid elevation of both TNF-α  gene expression and
protein release, we observed only a small effect of 1 mM
domoic acid on TNF-α  gene expression. Interestingly,
the slight rise in TNF-α  expression yielded a 53 % (p <
0.01) increase of TNF-α  protein release 4 hours after
stimulation with 1 mM domoic acid. Although we feel it
may be premature to speculate on the putative patho-
physiological significance of this increase in immunore-
active TNF-α , the fact that TNF-α  can induce MMP-9
expression in macrophages [47], suggests that TNF-α
may play an as yet undetermined role in the mechanism
of MMP-9 release observed in our studies. Futhermore
immuno-PCR techniques, which have allowed investiga-
tors to study the kinetics of TNF-α  release at the femto-
molar range [48], might help to study the kinetics of
picomolar microglia TNF-α  release triggered by a short-
term exposure to domoic acid. These proposed studies
might be of considerable significance in view of the fact
that similar amounts of TNF-α  release have also been
Figure 7
The time-course of MMP-2 and MMP-9 expression in
neonatal rat brain microglia cultured in the presence
of LPS or Domoic acid. MMP-2 and MMP-9 were deter-
mined as described in Materials and Methods. (A) SDS-PAGE
zymography (B) bar-graph depicting the quantitated results.
Neonatal rat brain microglia (2.8–5 ×  106 cells/culture dish)
were treated with LPS [10 ng/ml] or Domoic acid [1 mM] for
1–6 hours. Data (inverse o.d. units) are expressed as mean ±
SE of values obtained from 3 independent experiments. **p <
0.01 vs. vehicle control.BMC Pharmacology 2001, 1:7 http://www.biomedcentral.com/1471-2210/1/7
observed after a 2 hour stimulation of rat neonatal mi-
croglia with kainic acid, a domoic acid and glutamate an-
alog [41]. Taken together, our results with domoic acid as
well as those of Noda et al. [41]with kainic acid support
the recently proposed notion that TNF-α  might not be
neurotoxic in some situations when the release of this
mediator is low, and therefore might not be a necessary
requirement for neuronal death involving excitatory
amino acids [49].
Proteases such as MMP-9 [9], which have been implicat-
ed in sublethal and lethal neuronal and glial injury in
vivo in "...central nervous system diseases..." [50] are
released by LPS-activated rat neonatal microglia in vitro
[7], by a mechanism that may involve TNF-α  [47,51].
Clearly because in our studies 1 mM domoic acid stimu-
lated both an increase in TNF-α  release, as well as MMP-
9, further investigation of a possible relationship be-
tween these two events may be important. Furthermore,
though the magnitude of MMP-9 secretion stimulated by
domoic acid was lower than the one observed with LPS,
this is the first observation to our knowledge that an ex-
citatory amino acid like domoic acid is able to trigger
MMP-9 release in vitro. Although at the present time it
is difficult to comment on the pathophysiological signif-
icance of increased MMP-9 release, it is perhaps note-
worthy that increased MMP-9 expression has been
correlated with increased apoptosis [52] and increased
microvascular permeability [53], events possibly in-
volved in the opening of the blood-brain barrier [54] and
potential injury to the brain [50].
Microglia constitute the main leukocyte-dependent
source of reactive oxygen species in the central nervous
system [55]. Since microglia were first shown to release
O2- [6] numerous investigations have been undertaken
over the past 14 years to characterize agents than can ei-
ther prime and/or trigger the microglia O2- generating
system (for review see Ref. [3]). In our current experi-
ments, we observed that 1 mM domoic acid did not prime
rat neonatal microglia for PMA-stimulated O2- release,
again in marked contrast with LPS. Interestingly though,
domoic acid appeared to modulate LPS-primed rat neo-
natal microglia O2- release, suggesting that domoic acid
might potentially play a role in the in vivo modulation of
activated rat neonatal microglia, and perhaps other leu-
kocytes capable of releasing O2-.
In summary, in our experiments the in vitro effect of a 1–
6 hour exposure to domoic acid on rat neonatal microglia
activation and concomitant TNF-α , MMP-9 and O2- re-
lease was clearly distinct in its magnitude from that ob-
served after exposure to LPS, an agent involved in
endotoxic shock and other central nervous pathologies
[3]. Even though this present study was limited to the
study of the in vitro effects of domoic acid on three mi-
croglia mediators, namely TNF-α , MMP-9 and O2-, it
provides the first experimental evidence to our knowl-
edge that domoic acid, at in vitro concentrations that are
toxic to neuronal cells, can trigger a limited activation of
rat neonatal microglia and the concomitant release of
Figure 8
The effect of LPS and Domoic acid on neonatal rat
brain microglia O2- release. O2- generation was deter-
mined as described in Materials and Methods. (A) Neonatal
rat brain microglia (250,000 cells/well) were pretreated with
LPS [10 ng/mL] and/ or Domoic acid [1 mM] for 6 hours and
then stimulated with PMA [1 µM] for 2 hours. (B) Neonatal
rat brain microglia (250,000 cells/well) were first pretreated
with LPS [10 ng/mL] for 6 hours and then stimulated with
PMA [1 µM] ± Domoic acid [0–1 mM] for 2 hours. Data (O2-
nanomoles/2 hours) are expressed as mean ± SD of values
obtained from three culture wells of one representative
experiment. **p < 0.01 vs. untreated control.BMC Pharmacology 2001, 1:7 http://www.biomedcentral.com/1471-2210/1/7
modest though statistically significant amounts of TNF-
α  and MMP-9.
Our investigation does not exclude the possibility that in
vitro domoic acid may affect expression of genes and me-
diators that might support survival of neuronal cells.
Several lines of evidence appear to support this possibil-
ity. Thus, in a recent report ionotropic AMPA glutamate
receptors were shown to "...function not only as ion
channels but also as cell-surface transducers by means
of their interaction with the Src-family non-receptor
protein kinase Lyn...", ultimately leading to "...expres-
sion of brain-derived neurotrophic factor (BDNF) mes-
senger RNA" in cerebellar primary culture neurons [56].
In another study, basic fibroblast growth factor (bFGF)
was shown to significantly protect cerebellar granule
neurons in culture from the neurotoxicity by domoic ac-
id, perhaps "...through a direct interaction of bFGF and
bFGF receptors on the neuronal surface..." [32]. Inter-
estingly, because rat neonatal microglia have been
shown to express BDNF [57] and bFGF [58], and in view
of the fact that LPS can affect BDNF gene expression in
rat neonatal microglia cells [59], experiments are cur-
rently underway in our laboratory to determine if domoic
acid may affect neonatal rat microglia expression of both
BDNF and bFGF. However, we do not rule out the possi-
bility that growth factors other than BDNF and bFGF
could be released by domoic acid-stimulated neonatal
microglia cells and play a role in neuroprotection from
excitotoxic injury.
Conclusions
Our present results provide the first experimental evi-
dence to support the hypothesis that a direct interaction
of domoic acid with rat neonatal microglia in vitro, leads
to the release of small but statistically significant
amounts of two potentially neurotoxic mediators, name-
ly TNF-α  and MMP-9 after a short-term in vitro expo-
sure. These observations are of considerable significance
if future research demonstrates that higher levels of
TNF-α  and MMP-9 are generated by neonatal rat micro-
glia as a result of either (1) a synergistic interaction be-
tween domoic acid "...when in association with subtoxic
concentrations of excitatory amino acids..." a combina-
tion that has been shown to increase the neurotoxicity of
domoic acid to primary cultures of cerebellar neurons
[31] or (2) an increase in the time of exposure to domoic
acid, as we have reported is the case with LPS [7]. The
fact that domoic acid has been shown to activate rat mi-
croglia several days after in vivo administration
[60]clearly raises this latter possibility.
An understanding of the potential neurotoxic and/or
neuroprotective effects of domoic acid in neonatal rats
will ultimately lead to a better understanding of domoic
acid's effect in neonatal human development. This con-
cept is supported by the established fact that glutamate
receptors are highly conserved between mammals [26].
Ultimately studies contributing to the characterization of
the early biochemical as well as cellular events subse-
quent to an intoxication with the marine toxin domoic
acid will yield new insights for the rationale development
of novel therapeutic interventions for the prevention and
treatment of amnesic shellfish poisoning.
Materials and Methods
Reagents
LPS B (Escherichia coli 026:B6) was obtained from Difco
Laboratories (Detroit, MI); crystalline lyophilized domo-
ic acid was purchased from Diagnostics Chemicals Ltd.
(Oxford, CT) and was dissolved in LPS-free water ob-
tained from GIBCO-BRL (Grand Island, NY) to prepare
a 12.5 mM stock [39] and stored at -80°C; goat anti-
mouse IgG conjugated with tetramethylrhodamine iso-
thiocyanate (TRITC) and goat anti-rabbit IgG conjugat-
ed with fluorescein isothiocyanate (FITC) were obtained
from Sigma Chemical Co. (St. Louis, MO). PMA was
maintained at -80°C as a 10 mM stock solution in DMSO.
Dulbecco's modified Eagle medium (DMEM) with high
glucose (4,500 mg/l), Neurobasal-A medium, serum-
free B-27 supplement. Hank's balanced salt solution
(HBSS), penicillin (P), streptomycin (S), trypsin
(0.25%)-EDTA (1 mM) and trypan blue were purchased
from GIBCO-BRL (Grand Island, NY); certified heat-in-
activated fetal bovine serum (FBS) was obtained from
Hyclone (Logan, UT); mouse anti-rat CD11b/c mono-
clonal antibody (OX-42) and rabbit anti-glutamate re-
ceptor (GluR4) polyclonal antibody were purchased
from Pharmingen (San Diego, CA). A LPS stock of 1 mg/
ml was prepared in a 0.9% sodium chloride nonpyrogen-
ic solution from Baxter Healthcare Corp. (Toronto, ONT,
Canada) and then diluted with DMEM plus 10% FBS plus
P and S to the appropriate concentration used in our ex-
periments. Both the LPS stock solution [10 ng/ml] and
dilutions were stored at -80°C, thawed prior to each ex-
periment and discarded after use.
LPS containment
To inactivate extraneous LPS, all glassware and metal
spatulas were baked for 4 hours at 180°C. Sterile and
LPS-free 75-and 162-cm2 vented cell culture flasks, 24-
well flat-bottom culture clusters, 96-well cell culture
clusters and disposable serological pipettes were pur-
chased from Costar Corporation (Cambridge, MA), while
polystyrene cell culture dishes (60 ×  15 mm) were ob-
tained from Corning Glass Works (Corning, NY). Sterile
and pyrogen-free Eppendorf Biopur pipette tips were
purchased from Brinkmann Instruments, Inc. (West-
bury, NY).BMC Pharmacology 2001, 1:7 http://www.biomedcentral.com/1471-2210/1/7
Electrospray mass spectrometry of domoic acid
The presence of undegraded domoic acid in the stock so-
lution (12.5 mM) and dilutions prepared with LPS-free
water was confirmed by electrospray mass spectrometry
prior to the experiments. Electrospray mass spectrome-
try was performed in the Mass Spectrometry Laboratory,
School of Chemical Sciences, University of Illinois. All
electrospray mass spectrometry spectra were acquired
on a Micromass Quattro triple quadruple mass spec-
trometer (Manchester, UK) employing a Megaflow probe
and ion source. The data were acquired in the continuum
mode. All solvents were Fisher Optima or Burdick and
Jackson Distilled-in-Glass grade. Deionized water was
obtained from a Barstead NANOpure system. Domoic
acid samples (10 µl) were diluted with 40 µl of 50/50
H2O/AcN with 0.1% formic acid as the mobile flow
phase. An aliquot (10 µl) was injected using a model 7125
Rheodyne valve with a 10 µl loop. The sample was neb-
ulized with dry nitrogen at a flow of 15 l/hr and the nitro-
gen bath gas flow as 300 l/h. The electrospray mass
spectrometry source was typically operated with 3.5 kV
on the electrospray mass spectrometry probe and 400
volts on the counter electrode at a temperature of 65°C.
The cone voltage was 25 volts. Normal electrospray mass
spectrometry spectra were acquired employing MS 1
over the desired mass range in 10-s at unit resolution
(50% valley). The mass scale of the instrument was cali-
brated employing CsI (4 mg/ml in 50/50 H2O/AcN).
Immunofluorescent labeling of GluR4 and CD11b/c on rat 
neonatal microglia
The α -amino-3-hydroxy-5-methyl-4-isoxazole propionic
acid (AMPA) glutamate-4 receptor subunit (GluR4) and
the integrin CD11b/c were visualized by indirect immun-
ofluorescence using a dual labeling procedure. Rat neo-
natal microglia on glass coverslips were fixed and
permeabilized in -20°C methanol for 10 min, and then
blocked with 10% goat serum in phosphate buffered sa-
line (PBS) at 25°C for 5 min. The samples were incubated
for 45 min at 37°C in PBS containing the primary anti-
bodies, a rabbit anti-rat GluR4 at a 1:50 dilution, and a
mouse anti-rat CD11b/c (OX-42) at a 1:100 dilution.
Control samples were incubated in the same manner ex-
cept the primary antibodies were omitted from the solu-
tion. The samples were rinsed quickly in PBS and then
incubated for 30 minutes at 37°C in PBS containing the
secondary antibodies, a FITC-conjugated goat anti-rab-
bit IgG at a dilution of 1:50 and a TRITC-conjugated goat
anti-mouse IgG at a dilution of 1:400. The samples were
rinsed successively in PBS and deionized water and then
were mounted on glass slides in Aqua Polymount from
Polysciences, Inc. (Warrington, PA). The samples were
allowed to dry in the dark and were viewed using a 100 ×
objective lens on a Nikon Eclipse E400 epifluorescence
microscope from Nikon Inc. (Melville, NY). Digital imag-
es of the cells were captured with a Spot 2 digital camera
from Diagnostic Instruments, Inc. (Sterling Heights, MI)
and processed by using the Image-Pro Plus image analy-
sis computer program from Media Cybernetics, Inc. (Sil-
ver Spring, MD).
Isolation and culture of rat neonatal microglia
All experiments were performed with adherence to the
National Institutes of Health guidelines on the use of ex-
perimental animals and with protocols approved by Mid-
western University's Research and Animal Care
Committee. To isolate rat neonatal microglia, cerebral
cortices of 1–2 day-old Sprague-Dawley rats purchased
from Harlan (Indianapolis, IN) were surgically removed
and placed in cold DMEM + 10% FBS +120 U/ml P and
12 µg/ml S, the meninges carefully removed, and brain
tissue minced and dissociated with trypsin-EDTA at
36°C for 3–5 min. The mixed glial cell suspension was
plated in either 75- or 162-cm2 vented cell culture flasks
with DMEM medium supplemented with 10% FBS +120
U/ml P + 12 µg/ml S and grown in a humidified 5% CO2
incubator at 36°C for 12–14 days. On day 14 and every 3–
4 days thereafter, microglia were detached using an or-
bital shaker (150 rpm, 0.5 hours, 36°C, 5% CO2), centri-
fuged (400 ×  g, 25 min, 4°C), and microglia number and
viability assessed by trypan blue exclusion. Microglia
were characterized as described earlier [7]. Depending
on the particular experimental protocol (see below), mi-
croglia averaging > than 95% viability were plated in ei-
ther 60 mm ×  15 mm polystyrene cell culture dishes, 96-
well cell culture clusters, or 24-well cell culture clusters,
with DMEM supplemented with 10% FBS + 120 U/ml P
+ 12 µg/ml S, and placed in a humidified 5% CO2 incuba-
tor at 36°C 18–24 hours prior to the experiments.
Primary culture of rat cerebellar granule neurons
Primary cultures of rat cerebellar granule neurons were
prepared from the cerebella of 7-day-old Sprague-Daw-
ley rats. Cerebella were dissected and processed as de-
scribed elsewhere [61]. The dissociated cells were grown
in a serum-free Neurobasal-A medium with B27 supple-
ment (10 ml/500 ml) [62], and in the presence of 25 mM
KCl (Sigma). The cells were maintained in poly-L-lysine-
treated (10 ug/ml; Sigma) 96-well plates (60,000 cells/
0.1 ml Neurobasal A medium/well), at 37°C in an incuba-
tor with 95% air/5% CO2. This method results in a cul-
ture consisting of neuronal precursors that differentiate
into neurons; the differentiated cultures were used for
experiments after 10 days.
Experimental protocol to determine the viability of domo-
ic acid-treated rat neonatal microglia or cerebellar granule 
neurons
A colorimetric assay for the quantitation of cell viability,
based on the cleavage of the tetrazolium salt WST-1 (4-BMC Pharmacology 2001, 1:7 http://www.biomedcentral.com/1471-2210/1/7
[3-(4-Iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazo-
lio]1,3-benzene disulfonate) (slightly red) to formazan
(red) by mitochondrial dehydrogenases in viable cells
was utilized for these studies. Briefly, rat neonatal micro-
glia or cerebellar granule cells (60,000 cells / well) were
plated in LPS-free 96-well cell culture clusters 24 hours
prior to the experiments in either 0.1 ml DMEM supple-
mented with 10% FBS + 120 U/ml P + 12 µg/ml S (micro-
glia), or 0.1 ml serum-free Neurobasal A medium with
B27 supplement (cerebellar granule neurons). Thereaf-
ter each well received 4 µl of domoic acid (0.01 µM – 1
mM final concentration) or vehicle (LPS-free water) and
10 µl of the tetrazolium salt WST-obtained from Roche
Diagnostics Gmbh (Mannheim, Germany). Plates were
incubated in a humidified 5% CO2 incubator at 36°C and
the reduction of the WST-1 reagent to formazan was
measured repeatedly after the addition of the WST-1 re-
agent, at either 415 nM (neurons) or 450 nM (microglia),
with a microtiter plate (ELISA) reader.
Experimental protocol to determine the effect of domoic 
acid and LPS on rat neonatal microglia release of TNF-α , 
MMP-2, MMP-9 and O2-
To study the time-dependent effects of domoic acid and
LPS on the generation of TNF-α , MMP-2 and MMP-9,
rat neonatal microglia (2.8–5 ×  106 cells/60 mm ×  15 mm
polystyrene cell culture dish) were treated with (1) 1 mM
domoic acid, (2) LPS-free water used as a vehicle for do-
moic acid or (3) 10 ng/ml LPS in a final volume of 5 ml of
DMEM supplemented with 10% FBS + 120 U/ml P + 12
µg/ml S and incubated in a humidified 5% CO2 incubator
at 36°C for 1 to 6 h. Upon termination of the experi-
ments, cell-free supernatants from each culture dish
were assayed for TNF-α , MMP-2 and MMP-9, while rat
neonatal microglia were processed for RNA isolation and
RT-PCR. For the O2- assay, rat neonatal microglia
(250,000 cells/ 24-well cell culture clusters) were treat-
ed with (1) 1 mM domoic acid, (2) LPS-free water used as
a vehicle for domoic acid or (3) 10 ng/ml LPS in a final
volume of 1 ml of DMEM supplemented with 10% FBS +
120 U/ml P + 12 µg/ml S and incubated in a humidified
5% CO2 incubator at 36°C for 1 to 6 hours. Thereafter the
media was removed, 1 ml warm HBSS was added, and rat
neonatal microglia were stimulated with PMA [1 µM] for
120 min and O2- production was assayed as described
below.
Experimental protocol to determine the effect of domoic 
acid and LPS on rat neonatal microglia TNF-α  expression: 
RNA isolation and semiquantitative RT-PCR analysis
Total rat neonatal microglia RNA was isolated with TRI
reagent purchased from Molecular Research Center, Inc.
(Cincinnati, OH). The RT-PCR were performed in the
same sample tube using gene-specific primers obtained
from IDT (Coralville, IA), as described below, and the
Superscript one-step kit obtained from Gibco-BRL
(Grand Island, NY). Briefly, first strand cDNA was made
using 0.25 µg of RNA, Superscript II H-reverse tran-
scriptase, antisense gene-specific primers and condi-
tions of 30 min at 50°C. Samples were denatured at 94°C
for 2 min, and PCR was performed for various cycle
numbers to ensure linear amplification. The PCR cycling
conditions consisted of a denaturation step at 94°C for
30 s, an annealing step at 54°C (S12) or 60°C (TNF-α ), an
extension step at 72°C for 1 min, and a final extension
step at 72°C for 10 min. The 50 µl samples contained 0.2
mM of each dNTP, 1.2 mM magnesium sulfate. Plati-
num® taq DNA polymerase, and 0.2 µM of each gene
specific primer. The primers for rat TNF-α , were de-
signed using the DNASTAR Lasergene software (Madi-
son, WI) and the rat TNF-α  cDNA sequence (GenBank
accession number NM 012675), and are sense (bp 127 –
150):5'-GGG GCC ACC ACG CTC TTC TGT CTA-3' and
antisense (bp 285 – 307): 5'-CCT CCG CTT GGT TTG
CTA CG-3', and generate a 181 bp cDNA product. The
primers for rat constitutively expressed ribosomal S12,
were sense:5'-ACG TCA ACA CTG CTC TAC A-3' and an-
tisense:5'-CTT TGC CAT AGT CCT TAA C-3' and gener-
ate a 303 bp cDNA product as previously described [63].
Controls for RT-PCR included samples without the en-
zyme reverse transcriptase and samples without tem-
plate. The PCR reactions were analyzed by
electrophoresis using 1.5 % agarose gels, visualized with
SYBR® Gold nucleic acid staining (Molecular Probes;
Eugene, OR), photographed, scanned and digitized with
the UN-SCAN-IT™ gel automated digitizing system from
Silk Scientific (Orem, UT). The relative amounts of TNF-
α  expression as determined by RT-PCR were normalized
to S12 levels using methods similar to those previously
described by others [64].
Assays for TNF-α  and O2-. TNF-α
Immunoreactive TNF-α  in cell-free media supernates
was determined using an ultrasensitive rat-specific ELI-
SA for TNF-α  purchased from Biosource International
(Camarillo, CA) with a detection limit of 0.7 pg/ml. Re-
sults are expressed as pg/ml. O2- : O2- generation was
determined by the SOD-inhibitable reduction of FCC [7].
Briefly, O2- release from microglia was measured in the
presence of FCC (50 µM) and HBSS, with or without
SOD (700 Units). All experimental treatments were run
in triplicate and in a final volume of 1 ml. Changes in FCC
absorbance were measured at 550 nm using a Beckman
DU-650 spectrophotometer and O2- generation ex-
pressed in nmol by employing the molecular extinction
coefficient of 21.0 ×  103 M-1 cm-1.BMC Pharmacology 2001, 1:7 http://www.biomedcentral.com/1471-2210/1/7
SDS-PAGE gelatinase zymography for MMP-2 and MMP-
9 analysis
Following incubation with LPS or domoic acid, MMP ex-
pression was analyzed in the harvested media of cultured
rat neonatal microglia. As the rat neonatal microglia cul-
tures were normalized for cell number, equal volumes of
harvested media obtained from each condition were an-
alyzed. Briefly, 10 µl of each sample were electro-
phoresed at 4°C and under non-denaturing conditions
using a 10% polyacrylamide gel containing 0.05% gela-
tin. The gels were incubated for 1 hour in a 2.5% Triton
X-100 solution and then washed twice with water (20
min each). The gels were then incubated for 24 hours at
37°C in 50 mM Tris-HCl buffer, pH 7.4, containing 5 mM
CaCl2. A duplicate negative control gel was incubated as
described above but in 50 mM Tris-HCl, pH 7.4 contain-
ing 10 mM EDTA instead of CaCl2. The gels were fixed
for 1 hour in 40% methanol /7% acetic acid and then
stained in Coomassie Blue Solution (Sigma), followed by
destaining in 10% methanol, 7% acetic acid. MMP activ-
ity was visualized as clear bands against a blue back-
ground. Gelatin-containing zymograms are typically
used to detect MMP-2 (72 kDa) and MMP-9 (92 kDa)
and their identification is based on molecular weight.
Relative clearing of each sample was quantitated by de-
termining the inverse optical density units using the NIH
Image software package (version 1.60). Values are repre-
sented as the mean ± SE and are presented as inverse op-
tical density. The value corresponding to background, a
region of equal area as that used to measure the cleared
bands and of a lane in which no sample was loaded, was
subtracted from each sample value.
Statistical analysis of the data
Data were analyzed with the PrismR software package
purchased from GraphPad (San Diego, CA.). One way
analysis of variance followed by Dunnett's test was per-
formed on all sets of data. LPS or domoic acid-treated
groups were compared with the vehicle-treated group,
shown as 0 or control in the corresponding figures. Dif-
ferences were considered statistically significant at p <
0.05 and reported in each figure legend.
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